Business / Finance

RSS

Merck secures worldwide rights to vernakalant i.v.

Merck, known as MSD outside the United States and Canada, and Astellas US LLC, the U.S. subsidiary of Astellas Pharma Inc. today announced that they have entered into an agreement under which Merck, through a subsidiary, will acquire the exclusive rights to develop and commercialize the investigational intravenous formulation of vernakalant (vernakalant i.v.) in Canada, Mexico and the United States from Astellas.

27 Jul 2011

NFIB: Some small businesses drop coverage

Supporters of the health care reform law say there are major flaws in a new survey of small businesses. They say the study, released Monday by the National Federation of Independent Business, mischaracterized key policies in the health care law.

27 Jul 2011

Watson second quarter net revenue increases 24% to $1.1 billion

Watson Pharmaceuticals, Inc. today reported net revenue of $1.1 billion for the second quarter ended June 30, 2011, an increase of 24 percent when compared to $875.3 million in the second quarter 2010.

26 Jul 2011

Cipher net revenue decreases to $0.7 million for Q2 2011

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three and six months ended June 30, 2011.

26 Jul 2011

Biogen Idec reports revenue of $1.2 billion for second quarter 2011

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its second quarter 2011 results.

26 Jul 2011

Centene reports diluted earnings per share of $0.54 for second quarter 2011

Centene Corporation today announced its financial results for the quarter ended June 30, 2011. The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.

26 Jul 2011

Taro second quarter net sales increase 14.2% to $111.6 million

Taro Pharmaceutical Industries Ltd. today provided unaudited financial results for the quarter and year to date periods ended June 30, 2011.

26 Jul 2011

Kinetic Concepts second quarter total revenue increases 4% to $519.8 million

Kinetic Concepts, Inc. today reported second quarter 2011 total revenue of $519.8 million, an increase of 4% from the second quarter of 2010.

26 Jul 2011

Covidien third quarter net sales increase 14% to $2.93 billion

Covidien plc today reported results for the third quarter of fiscal 2011. Net sales of $2.93 billion increased 14% from the $2.56 billion reported in the third quarter a year ago.

26 Jul 2011

The evolution of hospice from its charitable roots to big business

As hospice care has evolved from its charitable roots into a $14 billion business run mostly for profit, patients ... and their families have paid a steep price, according to lawsuits and federal investigations.

26 Jul 2011

Daiichi Sankyo to deploy Veeva CRM for strengthening customer engagements in the UK

Veeva Systems announced today that Daiichi Sankyo, one of the world's top 20 pharmaceutical companies, is replacing its legacy, on-premise Customer Relationship Management (CRM) system with Veeva CRM in the UK.

26 Jul 2011

BioSante second quarter net loss increases to $15.0 million

BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2011.

26 Jul 2011

Decision Resources announces acquisition of PharmaStrat

Decision Resources Group, one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired PharmaStrat, the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers.

26 Jul 2011

QRxPharma raises A$25 million, announces A$10.4 million Rights Issue

QRxPharma Limited is pleased to announce the successful completion of a placement to institutions and professional investors raising A$25 million which was significantly oversubscribed. The Placement was very well supported by both existing and new investors including Australia, US and UK based fund managers.

25 Jul 2011

Prasco to market and distribute authorized generic of Shionogi's PONSTEL

Prasco Laboratories, the Authorized Generics company, announced today it has signed a supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute Mefenamic Acid Capsules, USP 250 mg, the Authorized Generic version of Ponstel®. Prasco intends to begin shipping product immediately in the U.S. under the Prasco label.

25 Jul 2011

Sunshine Heart to sell 115 million shares of common stock in private placement

Sunshine Heart, Inc., today announced it has entered into definitive agreements with new and existing institutional investors in the United States and Canada to sell approximately 115 million shares of common stock in a private placement.

25 Jul 2011

HCA second quarter revenues increase 4% to $8.063 billion

HCA Holdings, Inc. today announced financial and operating results for the second quarter ended June 30, 2011.

25 Jul 2011

Roper Industries second quarter sales increase 23% to $700 million

Roper Industries, Inc. reported record financial results for the second quarter ended June 30, 2011.

25 Jul 2011

MiMedx second quarter revenue increases 85% to $1,929,000

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the second quarter and six months ended June 30, 2011.

25 Jul 2011

Sartorius sales revenue increases 12.2% to 353.7M euros in the first half of 2011

Sartorius, a leading international laboratory and process equipment provider, successfully closed the first half of 2011, with double-digit growth rates in sales revenue and earnings.

From Sartorius 25 Jul 2011